Susquehanna Portfolio Strategies’s Tourmaline Bio TRML Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-43,189	Closed	-$2.07M	–	1130
2025 Q3	$2.07M	Sell	43,189 -7,930	-16%	-$220K	0.03%	508
2025 Q2	$817K	Buy	+51,119	New	+$828K	0.02%	551

Susquehanna Portfolio Strategies's TRML Position: Q4 2025 in Review

Susquehanna Portfolio Strategies sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 43,189 shares — an estimated $2.07M sold.

Susquehanna Portfolio Strategies first reported a position in TRML in Q2 2025 and held it in 2 quarters. The position peaked at $2.07M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Susquehanna Portfolio Strategies reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 43,189 Tourmaline Bio shares in Q4 2025, an estimated $2.07M.
Susquehanna Portfolio Strategies first reported a position in Tourmaline Bio in Q2 2025 and held it in 2 quarters.
Susquehanna Portfolio Strategies's Tourmaline Bio position peaked at $2.07M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.